Key result
MLPA detects LDLR deletions in ~2% of FH patients, outperforming real-time PCR.
Observational (n=318)
Answers are grounded in this paper and cite their sources.
BACKGROUND: Familial Hypercholesterolemia (FH) is a common genetic disease and at the molecular level most often due to mutations in the LDL receptor gene. In genetically heterogeneous populations, major structural rearrangements account for about 5% of patients with LDL receptor gene mutations. METHODS: In this study we tested the ability of two different quantitative PCR methods, i.e. Real-Time PCR and Multiplex Ligation-Dependent Probe Amplification (MLPA), to detect deletions in the LDL receptor gene. We also reassessed the contribution of major structural rearrangements to the mutational spectrum of the LDL receptor gene in Denmark. RESULTS: With both methods it was possible to discriminate between one and two copies of the LDL receptor gene exon 5, but the MLPA method was cheaper, and it was far more accurate and precise than Real-Time PCR. In five of 318 patients with an FH phenotype, MLPA analysis revealed five different deletions in the LDL receptor gene. CONCLUSION: The MLPA method was accurate, precise and at the same time effective in screening a large number of FH patients for large deletions in the LDL receptor gene.
No takes yet. Share an insight, caveat, or question.
Damgaard et al. (2005) conducted an observational in Familial Hypercholesterolemia (n=318). Multiplex Ligation-Dependent Probe Amplification (MLPA) vs. Real-Time PCR was evaluated on Detection of large deletions in the LDL receptor gene. Multiplex Ligation-Dependent Probe Amplification (MLPA) detected 5 different LDL receptor gene deletions in 5 of 318 (1.6%) FH patients and was more accurate and precise than Real-Time PCR.
Synapse has enriched 10 related papers. Consider them for comparative context: